Eric Laille

6PUBLICATIONS
26CO-AUTHORS
Psychological methodology, design and analysisCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 08, 2023
Population Pharmacokinetics of Oral Azacitidine, and Exposure-Response Analysis in Acute Myeloid Leukemia.

Allison Gaudy, Eric Laille, Rochelle Bailey

|Jun 17, 2022
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.

Stéphane de Botton, Pau Montesinos, Andre C Schuh

|Mar 25, 2021
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes.

Guillermo Garcia-Manero, Valeria Santini, Antonio Almeida

|Aug 21, 2020
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study.

Roisin M Connolly, Eric Laille, Ulka Vaishampayan

|Dec 29, 2017
Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single-arm, open-label phase 2 study.

Xin Du, Yue-Yun Lai, Zhijian Xiao

Pageof 1

Frequent Collaborators

2 joint publications

Michelle A Rudek

2 joint publications

Paresh Vyas

1 joint publications

Olatunji B Alese

1 joint publications

R Donald Harvey